120 related articles for article (PubMed ID: 3938733)
1. Plasma concentration of prolactin during four-day osmotic pump infusion of thyrotropin-releasing hormone and vasoactive intestinal polypeptide in rats.
Niimi M; Takahara J; Kawanishi K
Endocrinol Jpn; 1985 Dec; 32(6):929-32. PubMed ID: 3938733
[TBL] [Abstract][Full Text] [Related]
2. [A study on the prolactin releasing mechanism using an in vitro perfusion system with a cell column of cultured rat anterior pituitary cells].
Kageyama J
Nihon Naibunpi Gakkai Zasshi; 1984 Oct; 60(10):1243-54. PubMed ID: 6440813
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
Michalkiewicz M; Suzuki M; Kato M
Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
[TBL] [Abstract][Full Text] [Related]
4. The effect of dopamine antagonists and/or VIP on TRH- or VIP-induced prolactin release in estrogen- and progesterone-treated ovariectomized rats.
Haisenleder DJ; Moy JA; Gala RR; Lawson DM
Proc Soc Exp Biol Med; 1988 Mar; 187(3):341-9. PubMed ID: 3126503
[TBL] [Abstract][Full Text] [Related]
5. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
[TBL] [Abstract][Full Text] [Related]
7. Effects of VIP, TRH, GABA and dopamine on prolactin release from superfused rat anterior pituitary cells.
Matsushita N; Kato Y; Shimatsu A; Katakami H; Yanaihara N; Imura H
Life Sci; 1983 Mar; 32(11):1263-9. PubMed ID: 6132313
[TBL] [Abstract][Full Text] [Related]
8. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
Watanobe H; Tamura T; Sasaki S; Takebe K
Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal polypeptide and thyrotropin-releasing hormone stimulate newly synthesized, not stored, prolactin.
Maas DL; Arnaout MA; Martinson DR; Erdmann MD; Hagen TC
Endocrinology; 1991 Feb; 128(2):1015-20. PubMed ID: 1899215
[TBL] [Abstract][Full Text] [Related]
10. VIP enhances TRH-stimulated prolactin secretion of pituitary tumours. Studies with 31P NMR.
Prysor-Jones RA; Silverlight JJ; Jenkins JS; Stevens AN; Rodrigues JL; Griffiths JR
FEBS Lett; 1984 Nov; 177(1):71-5. PubMed ID: 6437866
[TBL] [Abstract][Full Text] [Related]
11. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
Apfelbaum ME
Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
Aizawa T; Hinkle PM
Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
Shah GV; Wang W; Grosvenor CE; Crowley WR
Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
[TBL] [Abstract][Full Text] [Related]
14. The effects of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pseudopregnant rats.
Haisenleder DJ; Moy JA; Gala RR; Lawson DM
Endocrinology; 1986 Nov; 119(5):1989-95. PubMed ID: 3095097
[TBL] [Abstract][Full Text] [Related]
15. The effects of dopaminergic antagonism by sulpiride on TRH and VIP-induced prolactin release in nonsuckled lactating rats.
Haisenleder DJ; Moy JA; Lawson DM
Life Sci; 1990; 46(25):1867-72. PubMed ID: 2163481
[TBL] [Abstract][Full Text] [Related]
16. Physiological roles of thyrotrophin-releasing hormone and vasoactive intestinal peptide on the pulsatile secretory patterns of prolactin in pituitary-grafted female rats.
Lafuente A; Marcó J; Esquifino AI
J Endocrinol; 1994 Sep; 142(3):581-6. PubMed ID: 7964307
[TBL] [Abstract][Full Text] [Related]
17. Different prolactin, thyrotropin, and thyroxine responses after prolonged intermittent or continuous infusions of thyrotropin-releasing hormone in rhesus monkeys.
Pavasuthipaisit K; Norman RL; Ellinwood WE; Oyama TT; Baughman WL; Spies HG
J Clin Endocrinol Metab; 1983 Mar; 56(3):541-8. PubMed ID: 6401761
[TBL] [Abstract][Full Text] [Related]
18. Pituitary vasoactive intestinal peptide regulates prolactin secretion in the hypothyroid rat.
Lam KS; Reichlin S
Neuroendocrinology; 1989 Nov; 50(5):524-8. PubMed ID: 2514393
[TBL] [Abstract][Full Text] [Related]
19. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
20. Prolactin responses to vasoactive intestinal polypeptide and thyrotropin releasing hormone in chronic renal failure.
Arnaout MA; Hamzeh YS; Ajlouni KM
Acta Endocrinol (Copenh); 1991 Dec; 125(6):651-6. PubMed ID: 1789061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
